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Cells that have been irradiated with ultraviolet light (UV)
suffer damage to their DNA, primarily in the form of
covalent linkage between adjacent pyrimidines. Such
photoproducts represent blocks to RNA and DNA poly-
merases and are potentially mutagenic. Blockage of RNA
polymerase II by a photoproduct in the transcribed strand
of an active gene leads to induction of the p53 protein,
which induces pleiotropic responses that may include
apoptotic cell death. If a cell survives, the blocked poly-
merase targets the nucleotide excision repair machinery
to the site of the lesion, which is repaired in an error-
free manner. Repair coupled to transcription in this
manner strongly influences the mutation spectrum
induced by UV, reducing the proportion of base substitu-
MUTATIONS AND CANCER
Mutations are defined as stable and heritable changes in the DNA base
sequence. For example, mutations in conserved regions of the p53
tumor suppressor gene have been found very frequently in a variety
of human tumors, including sunlight-associated skin cancers (for review,
see Levine, 1997). These data and a large number of recent studies
indicate that mutational changes in a specific subset of genes (proto-
oncogenes and tumor suppressor genes) are causally involved in
neoplastic transformation. There are test systems available to measure
the frequency of mutation induction in cells in culture, including
human cells; however, the molecular mechanisms responsible for the
induction of the mutations are not well understood.
DNA DAMAGE AND MUTAGENESIS
When cells are exposed to an agent that chemically modifies the
structure of DNA, the DNA is said to be damaged. In the case of
UVB radiation, the absorption of photons by DNA opens the 5–6
double bond of pyrimidines. If two adjacent pyrimidines undergo this
5–6 double bond opening, they can form a stable ring structure referred
to as a cyclobutane pyrimidine dimer (CPD) (Fig 1A). The second
most common lesion formed in UV-damaged DNA is the pyrimidine
6–4 pyrimidone (6–4) (Fig 1B). This lesion results when a 5–6 double
bond in a pyrimidine opens and reacts with the exocyclic moiety of
the adjacent 39 pyrimidine to form the covalent 6–4 linkage. Depending
on sequence context, the ratio of CPD to 6–4 ranges from 3 or 4 to
1. Such damage alters the base-pairing ability of the involved bases
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tions that arise from photoproducts on the transcribed
strand. If the damage persists when the DNA is replicated
in S-phase, either because the cell is unable to repair
the damage or because there is insufficient time between
the induction of damage and the onset of S-phase. To
do so, the replicative DNA polymerase complex may be
blocked. In this situation, lesion bypass can be accomp-
lished using an error-free mechanism, or using an error-
prone mechanism that involves the newly described, non-
processive DNA polymerase ζ encoded by the human
homolog of the yeast REV3 gene. Key words: xeroderma
pigmentosum/DNA polymers/cyclobutane pyrimidine dimer/
6–4 photoproduct/REV3. Journal of Investigative Dermatology
Symposium Proceedings 4:1–5, 1999
and can be cytotoxic due to blockage of transcription and replication.
Photoproducts present very strong blocks to the progression of DNA
replication complexes in a variety of systems, including human cells
(Lawrence et al., 1993; Carty et al, 1993; Thomas and Kunkel, 1993;
Thomas et al, 1993; Svoboda and Vos, 1995). If bypass can be
accomplished in some way, such translesion synthesis may result in
insertion of an incorrect base across from the site of damage, in
the nascent DNA strand. The result is likely to be a stable,
heritable change in the DNA sequence. An important cellular
mechanism to avoid the potential mutational consequences of such
damage is to repair the damage through the process of nucleotide
excision repair in which the damage is recognized and removed. If the
damage is repaired by excision repair before the DNA sequence
containing a lesion is replicated, mutation formation is prevented.
NUCLEOTIDE EXCISION REPAIR AND MUTAGENESIS
Nucleotide excision repair (NER) is a highly evolutionarily conserved
strategy for repairing a wide variety of bulky DNA lesions, including
UV-induced CPD and 6–4s. As reviewed by Wood (1997), the essential
step in this process is incision on either side of the lesion to produce
a single-stranded fragment of 24–32 nucleotides. DNA polymerase
delta or epsilon with associated cofactors fills in the resulting gap.
Because the undamaged DNA is used as a template, and the polymerase
complex has very high fidelity, the process is essentially error free. The
importance of this process in the prevention of skin cancer is illustrated
by the greatly increased (.1000-fold) incidence of such cancers in
patients with the inherited disorder xeroderma pigmentosum (XP).
These patients have defects in some aspect of NER, and the study of
their cells has helped to dissect the pathway. Cleaver (1969) was the
first to recognize that XP cells were NER deficient. Cells from some
patients can complement, or fix, the defect in cells from other patients,
indicating that there is more than one molecular defect underlying the
disorder. There are now known to be seven genetic complementation
groups termed A through G, and, with the exception of XP-E, the
molecular defect in each has been identified, and the corresponding
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Figure 1. Structures of the major photoproducts induced in DNA by UV
light. (A) Cyclobutane pyrimidine dimer (CPD) between adjacent thymines.
Saturation of the 5–6 double bonds results in the formation of a cyclobutane
ring. The most prevalent isomer in double helical B-DNA is thought to be cis-
syn, in which the planes of the pyrimidine rings are parallel. (B) The 6–4
photoproduct between adjacent thymidines is formed by linkage between the
G position of the 59 base and the 4 position of the 39 base. The plane of the
39 base is perpendicular to the page, shifted 90° relative to that of the 59 base.
In DNA, the 39 base is typically cytosine rather than thymine.
Table I. Molecular defects in XP complementation groups
Proteina Defect
XPAb No lesion recognition
XPBc Reduced helicase activity that unwinds DNA 39 to 59 of the lesion
XPC Reduced recognition of lesions in global genome, normal
transcription -coupled repair
XPDc Reduced helicase activity that unwinds DNA 59 to 39 of the lesion
XPE ? Mutant UV-damaged DNA binding protein
XPF Mutant endonuclease that cuts 59 to the lesion
XPGd Mutant endonuclease that cuts 39 to the lesion
aCells from complementation groups signified with a hyphen (XP-A); the corresponding
proteins are not hyphenated (XPA).
bPatients are very severely affected and may have developmental defects.
cProteins also found in transcription factor TFIIH. Patients are likely to have
developmental abnormalities.
dDefective transcription-coupled repair of oxidative damage suggests a second,
nonendonucleolytic function for this protein. These patients may also have developmental
defects, possibly due to reduced repair of oxidative damage.
gene has been cloned (Table I). In addition, there is a variant form
(XP-V). These cells are not repair deficient (Tung et al, 1996; McGregor
et al, 1999).
Two overlapping NER pathways exist. Global genomic repair
removes lesions from transcriptionally silent regions of the genome
and from the nontranscribed strands of active genes. The XPC protein,
together with a homolog of yeast RAD 23 (hHR23B), has been shown
to bind to lesions in those regions and to target the excision apparatus
to them (Sugasawa et al, 1998; Hwang et al, 1999). Some, but not all,
lesions that occur in transcriptionally active regions of the genome are
repaired more rapidly than those that occur in transcriptionally silent
regions, and this is due to preferential, transcription-coupled repair
(TCR) of such lesions. A blocking lesion on the transcribed strand,
which inhibits the progress of RNA polymerase II, triggers TCR. In
a process that is not well understood, but that involves the Cockayne’s
syndrome A and B proteins, the stalled polymerase recruits the excision
repair apparatus to the site of the lesion. The polymerase itself is
probably displaced (Donahue et al, 1994), thereby allowing the lesion
to be recognized.
We wished to determine the effect of NER, including TCR, on
the kinds and locations of mutations that are induced by UV in an
endogenous target gene in human cells. To do this, it is necessary to
determine the repair characteristics of the major photoproducts in
the individual strands of a target gene that can also be used for
mutagenesis studies. The hypoxanthine (guanine) phosphoribosyltransferase
(HPRT) gene was chosen for these studies because it is transcriptionally
active, there is only one active copy due to its location on the X
chromosome, and the thioguanine assay is a convenient selection
system for mutations that affect enzyme function (Maher and McCorm-
ick, 1996). This assay is based on the fact that HPRT is required for
metabolism of the purine analog 6-thioguanine to a cytotoxic product,
but the enzyme is not required for normal cell growth. Therefore, if
a population of cells is plated in the presence of thioguanine, cells with
mutant (nonfunctional) HPRT will grow in a clonal fashion whereas
the cells expressing functional HPRT enzyme die. The mutant clones
can be easily identified for subsequent genetic analysis.
We determined the repair of CPDs in the 59 20 kb half of the
HPRT gene by irradiating cells with UV, then allowing various times
for repair (Tung et al, 1996). After the DNA was isolated and cut with
a restriction enzyme, it was exposed to T4 endonuclease V, a bacterial
enzyme that recognizes CPDs and makes single-strand incisions at
those sites. After the DNA was separated on a gel and transferred to a
membrane, the membrane was probed with RNA probes that recognize
and bind to one strand of DNA or the other. Damage in the 20 kb
fragment is reflected in reduced intensity of the DNA compared with
DNA that was not exposed to the endonuclease; conversely, repair of
the damage is reflected by increasing intensity of the fragment after a
period of repair. By sequential probing of the same blot, estimates of
rates of repair in the individual strands can be obtained. The results of
several experiments are shown in Fig 2(A). There is preferential repair
of CPDs, such that the half-life of these photoproducts in the transcribed
strand is only about 4 h, compared with about 8 h for those in the
complementary, nontranscribed strand. After 12 h of repair, 90% of
the CPD had been removed from the transcribed strand compared
with only 63% from the nontranscribed strand.
Cells were similarly evaluated for the repair of 6–4s, with the
modification that CPD were first reversed with bacterial photolyase,
then DNA that contained the 6–4 lesions was cut with UvrABC from
E. coli. (Tung et al, 1996) The results are shown in Fig 2(B). In
contrast to the results for CPDs, 6–4 repair is very rapid and is not
strand-specific; the half-life for these lesions in both strands is only
about 30 min, and virtually all have been removed within 2 h. The
very rapid repair of 6–4s has been postulated to occur because
the global genome repair system has an extraordinary affinity for
these photoproducts, causing them to be repaired even more
efficiently than by transcription-coupled mechanisms, which also
recognize such lesions (Van Hoffen et al, 1995). Hwang et al (1999)
have recently postulated that 6–4s anywhere in the genome are directly
recognized by the XPC/hHR23B heterodimer that is required for
global genomic repair. This complex can directly target the NER
apparatus to the site of such lesions. In contrast, CPDs in inactive
regions (which constitutes 95% of the genome) must first be recognized
by UV-damaged DNA binding protein, and this complex is in turn
recognized by XPC/hHR23B, which induces global genomic repair.
The CPDs in transcribed strands block RNA polymerase II, inducing
TCR. This explanation is consistent with the strand-specific and
generally slower repair of CPD.
The influence of NER on the UV-induced mutant frequency in
the HPRT gene is shown in Fig 3. In normal, repair-proficient cells,
the mutant frequency is highest when synchronized populations are
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Figure 2. Rate of repair of photoproducts in the individual strands of
the HPRT gene and in the genome overall, as a function of time after
irradiation (repair time). (A) Repair of CPDs. Each time point represents
the mean value of PhosphorImager scanning of Southern blots from three
independent biologic experiments. The CPD frequency in the HPRT fragment
was calculated from the ratio of the intensity of the HPRT band in treated and
untreated DNA, using the Poisson distribution equation. The UV254 fluence
was 10 J per m2. d, transcribed strand; s, nontranscribed strand. The dashed
line represents the data for rate of repair in the overall genome (Wang et al,
1993). (B) Repair of 6–4 photoproducts. The DNA was photoreactivated to
eliminate CPD, then exposed to UvrABC to measure 6–4s. The frequency of
6–4s in the gene fragment was determined as in (A). The UV254 fluence was
40 J per m2. Symbols as in (A). Note the different X-axis scales in parts (A)
and (B).
irradiated at the onset of S-phase. There is a dose-dependent increase in
the induced frequency, which is noted at fluences above approxi-
mately 2 J UV254 per m
2. Below this level, normal cells show no
cytotoxicity nor are mutations induced, i.e., the UV damage is
‘‘tolerated’’. At a given fluence of UV above this level, the induced
frequency declines as the time between irradiation and the onset of S-
phase increases. When cells are irradiated 6 h before S, the frequency
goes down by about one-half. When cells are irradiated 12 or more
hours before S, no induced mutations are observed. Both the tolerated
dose of 2 J per m2 and the mutant frequency decline are due to NER
because neither effect is observed in XP-A cells that are completely
deficient in NER (Fig 3). Note that in such cells, there is no tolerated
dose, the cells are extremely sensitive to the mutagenic (and cytotoxic)
effects of UV, and the mutant frequency does not decline as the time
between irradiation and the onset of S-phase increases.
Cells are known to undergo an S-phase arrest after exposure to UV.
The extremely rapid gene-specific repair of 6–4s predicts that most of
these lesions would be removed during this time. If so, then mutations
would arise primarily from CPDs remaining in the gene when DNA
replication resumed. Because the latter photoproducts are removed in
a strand specific manner, we hypothesized that the mutation spectrum
would reflect transcription-coupled repair of CPDs. To test this
hypothesis, i.e., to determine the effect of NER on the UV-induced
mutation spectrum, populations of repair-proficient cells were irradiated
at S or 6 h prior to S, mutants were identified, and the coding region
of the gene was sequenced (McGregor et al, 1991). These mutations
were compared with those derived from repair-deficient XP-A cells
that were similarly irradiated. For base substitutions in the coding region,
it is possible to determine the strand location of the photoproduct that
induced a given alteration. This is because the photoproduct virtually
always forms between adjacent pyrimidines, and the strand (transcribed
or nontranscribed) that harbored the photoproduct is therefore known.
As shown in Fig 4(A), when this analysis is applied to XP-A cells,
most (79%) of the mutations arose from photoproducts in the transcribed
strand, and this proportion did not change significantly when the cells
were irradiated 6 h before S. The high proportion of mutations that
arose from photoproducts in the transcribed strand can be partly
Figure 3. Frequency of mutants induced in the HPRT gene by UV254,
in repair-deficient or -proficient human cells. Synchronized populations
of cells were irradiated at the beginning of S-phase (S) or in G1-phase, 6 h
prior to the onset of DNA synthesis (G1). After an expression period, the cells
were assayed for thioguanine resistance. XP-A, cells derived from a xeroderma
pigmentosum complementation group A patient (XP12BE). These cells have
no detectable excision repair of photoproducts, and the mutant frequency does
not change when the cells are irradiated in G1. NF, normal human fibroblasts
derived from neonatal foreskin. The repair characteristics of these cells are
shown in Fig. 1. The results are from a single representative experiment.
explained by the 59:41 preponderance of dipyrimidine sites in that
strand of the gene. When this analysis is applied to repair-proficient
cells (Fig 4B), the most striking finding is that there is a dramatic
reduction in the frequency of mutations that arise from photoproducts
on the transcribed strand as the time for DNA repair to act on the
gene increases prior to the onset of S-phase. In repair proficient cells
irradiated at the beginning of S, which have little time to repair before
S, 75% of the mutations arise from lesions on the transcribed strand.
In contrast, after 6 h of repair the proportion is reversed, i.e., only
20% arise from the transcribed strand. These data are interpreted to
mean that TCR is responsible for specifically reducing the frequency
of mutations that arise in transcriptionally active genes by rapidly
removing photoproducts from the transcribed strand. This effect,
together with the removal of RNA polymerase blockade, may be the
reason that TCR is highly conserved in all eukaryotic cells.
DNA REPLICATION AND MUTAGENESIS
The S-phase dependence of UV-induced mutations in repair-proficient
cells (Fig 3) implies that most mutations occur when the DNA
replication complex encounters unrepaired damage in the template,
and that translesion synthesis is central to the process of mutagenesis
in human cells. The mechanisms used to bypass DNA damage by
higher eukaryotic cells, including human, are poorly understood;
however, these mechanisms are being elucidated in yeast, and this has
allowed us to extend this analysis to human cells.
The RAD genes of the budding yeast S. cerevisiae control resistance
to UV and/or ionizing radiation, and to certain chemicals. These genes
fall into three broad groups that were originally defined by synergistic
radiation sensitivity of double mutants. These groups (named for a
prototype gene) are RAD3, nucleotide excision repair, and transcrip-
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Figure 4. Transcription-coupled repair of CPD reduces the proportion
of mutations that arise from photoproducts in the transcribed strand
of the HPRT gene. The coding region of the HPRT gene from mutant cells
irradiated as in Fig. 3 (XP-A, 0.5 J per m2; NF, 6.5 J per m2) was
amplified by RT-PCR, and sequenced. The strand location of the premutagenic
photoproducts was assigned (see text). (A) XP-A fibroblasts; (B) normal
fibroblasts.
tion; RAD52, double-strand break repair, and recombination; and
RAD6, mutagenesis, and damage tolerance. The RAD6 pathway is
the least understood, but it nevertheless contributes substantially to
resistance to DNA damage and to mutagenesis resulting from such
damage in yeast (Lawrence, 1994). Three members of this group, the
REV1, 3, and 7 genes (UV-reversionless), are of particular interest
because they are responsible for mutagenic bypass of DNA damage.
REV3 encodes a protein with sequence motifs characteristic of a DNA
polymerase (Morrison et al, 1989), but the gene is not transcriptionally
regulated like replicative polymerases (Singhal et al, 1992). REV7
encodes a protein with no similarity to any other protein in the
databases (Torpey et al, 1994). The REV3 and REV7 gene products form
a complex with DNA polymerase activity, termed DNA polymerase ζ
(Nelson et al, 1996a). REV1 is in the umuC superfamily, and may
facilitate bypass by pol ζ (Nelson et al, 1996b). Deletion of any of
these genes results in a similar phenotype: normal viability in the
absence of DNA damage, moderately reduced viability in the presence
of damage, and greatly reduced spontaneous (Roche et al, 1994, 1995;
Kalinowski et al, 1995) and induced (Lawrence, 1994) mutagenesis.
The REV3 gene encodes a 173 kDa protein that is the catalytic
subunit of DNA polymerase ζ, an enzyme that appears to be dedicated
to translesion synthesis, performing no other known function in
replication, recombination, or repair (Nelson et al, 1996a). This
polymerase contains a second subunit, the 29 kDa product of the
REV7 gene, of unknown function. Polymerase ζ is a nonprocessive
enzyme, adding three or fewer nucleotides per binding/dissociation
cycle, and lacks 39-59 exonuclease proofreading activity. The enzyme
can bypass a TT CPD about one out of 10 times; in contrast, yeast
pol α is virtually incapable of bypassing these lesions. The REV1 gene
encodes a 112 kDa protein that possesses two functions: a general
function necessary for the bypass of potentially replication-blocking
lesions by pol ζ, and a deoxycytidyl transferase activity that inserts
dCTP opposite abasic sites in the template (Nelson et al, 1996b).
The sequence of the yeast REV3 gene has been used to isolate the
human homolog, designated REV3L. The human gene encodes an
expected protein of 3130 residues (~353 kDa), about twice the size of
the yeast protein (Gibbs et al, 1998). The yeast and expected human
Figure 5. Expression of antisense to the human homolog of the yeast
REV3 gene reduces the UV-induced mutant frequency. Populations of
cells that did not express antisense (parental) or expressed high levels of REV3L
antisense were irradiated with UV254, then assayed for thioguanine resistance.
protein show 29% identity within an amino terminal region of ~350
residues, 39% identity in an amino terminal region of ~850 residues,
and 29% identity within an internal region of 55 residues. The predicted
human protein also possesses internal regions of ~1550 and ~330
residues that have no similarity to yeast sequences. The in vivo function
of REV3L was investigated by expressing high levels of a REV3L
antisense RNA fragment in human fibroblasts. As shown in Fig 5, in
cells that express high levels of antisense the frequency of UV-induced
mutants resistant to 6-thioguanine is at least 10-fold lower than in
parental cells that do not express antisense. Although not shown, the
UV toxicity is slightly greater in the antisense expressing cells. The
yeast and human genes therefore appear to perform a similar function.
In addition, unirradiated cells containing high levels of antisense RNA
grow normally, suggesting that, like the yeast counterpart, the REV3L-
encoded protein is not required for viability.
In addition to the REV gene products, minimal requirements for
lesion bypass in yeast include the products of the RAD6 and RAD18
genes. The proteins are a ubiquitin-conjugating enzyme (Rad6p) and
a DNA binding protein (Rad18p); the targets for the presumed
ubiquitylation activity of this complex have yet to be identified.
Interestingly, the Rad6-Rad18 complex is also required for error-free
translesion synthesis by the newly described DNA polymerase η
(Johnson et al, 1999), and for avoidance of lesions by the replicative
polymerase complex itself. The latter mechanism has not been well
defined, but involves selective copying of information on the undam-
aged strand. The error-free mechanisms are responsible for at least 95
out of 100 bypass events (Baynton et al, 1998), rendering the error-
prone pathway involving the REV gene products a minor pathway
that is responsible nevertheless for virtually all UV-induced mutagenesis
in yeast. The identification of a human homolog to the RAD6 gene
(Koken et al, 1991) and to other genes in this pathway (Gibbs et al,
1998; Xiao et al, 1998) raises the likelihood that these strategies have
been conserved.
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SUMMARY
Ultraviolet radiation is a ubiquitous mutagen, and cells have evolved
multiple mechanisms for ameliorating the effects of genetic damage
resulting from exposure. In human cells, photoproducts in DNA lead
to an accumulation of p53 protein; one of the major triggers for this
may be RNA polymerase molecules that are stalled by photoproducts
on the transcribed strand of active genes. The p53 protein has a wide
variety of cellular effects, including the triggering of the apoptotic
cascade resulting in cell death. If a damaged cell survives, the damage
may be repaired by NER in an error-free process that returns the
DNA to its original sequence. Thus, the effect of NER is to reduce
the mutagenic, and, by extension, the carcinogenic effect of UV. A
comparison of UV mutational spectra induced in cells that have not
repaired damage with those from cells that have done so indicates that
TCR has a profound effect on the location of mutations. In particular,
the normal repair process greatly reduces the frequency of mutations
that arise from photoproducts in the transcribed strand of active genes.
This has the effect of specifically lowering the number of mutations
that arise in active genes, where sequence alterations would be expected
to have the greatest detrimental effect on cell biochemistry. In repair-
proficient cells, the induced mutation frequency in a given gene is
highest when the cells are irradiated at the onset of S-phase just before
the gene is replicated. This indicates that the majority of mutations
occur when a damaged DNA template is replicated. Recent data
indicate that such damage may be tolerated using error-free or error-
prone pathways. The error-free mechanism accounts for the great
majority of lesion bypass events. There may be direct, error-free
translesion synthesis by DNA polymerase η or the damage may be
avoided by the replicative polymerases with additional cofactors that
facilitate the selective copying of information in the undamaged strand.
The error-prone pathway is a minor pathway that is responsible for
most UV-induced mutations. It requires DNA polymerase ζ which
directly accomplishes lesion bypass and is likely to make errors when
doing so. The question of why such a mutagenic bypass system persists
in higher eukaryotes remains unresolved. In addition, the regulatory
processes that govern the choice of error-free or error-prone pathways,
and the mechanisms by which the accessory DNA polymerases associate
with, or displace, the normal replication complex are important
problems that remain to be investigated.
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